The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:** William Ackman's Pershing Square Capital Management proposed a slate of six directors for the board of Allergan Inc as the hedge fund presses forward with its $53 billion takeover bid with Valeant Pharmaceuticals International Inc for the Botox maker.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 1.94% or $-3.28/share to $165.85. In the past year, the shares have traded as low as $83.95 and as high as $174.49. On average, 4500290 shares of AGN exchange hands on a given day and today's volume is recorded at 1678936.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 2.15% or $-2.71/share to $123.29. In the past year, the shares have traded as low as $88.01 and as high as $153.10. On average, 3690450 shares of VRX exchange hands on a given day and today's volume is recorded at 1679756.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.83% or $-1.1/share to $131.90. In the past year, the shares have traded as low as $92.42 and as high as $170.45. On average, 385119 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 343459.
Source